Literature DB >> 19494074

Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions.

Noriaki Hosoya1, Zhaohui Su, Timothy Wilkin, Roy M Gulick, Charles Flexner, Michael D Hughes, Paul R Skolnik, Françoise Giguel, Wayne L Greaves, Eoin Coakley, Daniel R Kuritzkes.   

Abstract

Detection of CXCR4-using human immunodeficiency virus by the Trofile assay was compared to that by assays using virus isolates or replication-competent recombinants. Concordance with the Trofile assay was good, but assays using replicating viruses did not increase substantially the ability to detect the presence of CXCR4-using virus.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19494074      PMCID： PMC2725648          DOI： 10.1128/JCM.00632-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism.

Authors:  Jeannette M Whitcomb; Wei Huang; Signe Fransen; Kay Limoli; Jonathan Toma; Terri Wrin; Colombe Chappey; Linda D B Kiss; Ellen E Paxinos; Christos J Petropoulos
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

2.  Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.

Authors:  A Björndal; H Deng; M Jansson; J R Fiore; C Colognesi; A Karlsson; J Albert; G Scarlatti; D R Littman; E M Fenyö
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter.

Authors:  Lisa M Demeter; Ronald J Bosch; Robert W Coombs; Susan Fiscus; James Bremer; Victoria A Johnson; Alejo Erice; J Brooks Jackson; Stephen A Spector; Kathleen M Squires; Margaret A Fischl; Michael D Hughes; Scott M Hammer
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.

Authors:  Timothy J Wilkin; Zhaohui Su; Daniel R Kuritzkes; Michael Hughes; Charles Flexner; Robert Gross; Eoin Coakley; Wayne Greaves; Catherine Godfrey; Paul R Skolnik; Joseph Timpone; Benigno Rodriguez; Roy M Gulick
Journal:  Clin Infect Dis       Date:  2007-01-17       Impact factor: 9.079

5.  Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.

Authors:  G Simmons; D Wilkinson; J D Reeves; M T Dittmar; S Beddows; J Weber; G Carnegie; U Desselberger; P W Gray; R A Weiss; P R Clapham
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.

Authors:  Roy M Gulick; Zhaohui Su; Charles Flexner; Michael D Hughes; Paul R Skolnik; Timothy J Wilkin; Robert Gross; Amy Krambrink; Eoin Coakley; Wayne L Greaves; Andrew Zolopa; Richard Reichman; Catherine Godfrey; Martin Hirsch; Daniel R Kuritzkes
Journal:  J Infect Dis       Date:  2007-06-05       Impact factor: 5.226

7.  HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay.

Authors:  M Koot; A H Vos; R P Keet; R E de Goede; M W Dercksen; F G Terpstra; R A Coutinho; F Miedema; M Tersmette
Journal:  AIDS       Date:  1992-01       Impact factor: 4.177

8.  Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.

Authors:  H Schuitemaker; M Koot; N A Kootstra; M W Dercksen; R E de Goede; R P van Steenwijk; J M Lange; J K Schattenkerk; F Miedema; M Tersmette
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

9.  Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.

Authors:  L Zhang; T He; Y Huang; Z Chen; Y Guo; S Wu; K J Kunstman; R C Brown; J P Phair; A U Neumann; D D Ho; S M Wolinsky
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

Authors:  Gerd Fätkenheuer; Mark Nelson; Adriano Lazzarin; Irina Konourina; Andy I M Hoepelman; Harry Lampiris; Bernard Hirschel; Pablo Tebas; François Raffi; Benoit Trottier; Nicholaos Bellos; Michael Saag; David A Cooper; Mike Westby; Margaret Tawadrous; John F Sullivan; Caroline Ridgway; Michael W Dunne; Steve Felstead; Howard Mayer; Elna van der Ryst
Journal:  N Engl J Med       Date:  2008-10-02       Impact factor: 176.079
View more
  4 in total

1.  The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates.

Authors:  Nina H Lin; Daniel M Negusse; Rameen Beroukhim; Francoise Giguel; Shahin Lockman; Myron Essex; Daniel R Kuritzkes
Journal:  J Virol Methods       Date:  2010-06-25       Impact factor: 2.014

2.  TROCAI (tropism coreceptor assay information): a new phenotypic tropism test and its correlation with Trofile enhanced sensitivity and genotypic approaches.

Authors:  Alejandro Gonzalez-Serna; Manuel Leal; Miguel Genebat; Maria Antonia Abad; Antonio Garcia-Perganeda; Sara Ferrando-Martinez; Ezequiel Ruiz-Mateos
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

Review 3.  Tropism testing in the clinical management of HIV-1 infection.

Authors:  Nina H Lin; Daniel R Kuritzkes
Journal:  Curr Opin HIV AIDS       Date:  2009-11       Impact factor: 4.283

4.  HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalization.

Authors:  Christian Pou; Francisco M Codoñer; Alexander Thielen; Rocío Bellido; Susana Pérez-Álvarez; Cecilia Cabrera; Judith Dalmau; Marta Curriu; Yolanda Lie; Marc Noguera-Julian; Jordi Puig; Javier Martínez-Picado; Julià Blanco; Eoin Coakley; Martin Däumer; Bonaventura Clotet; Roger Paredes
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.